Display options
Share it on

Exp Ther Med. 2016 Aug;12(2):1232-1242. doi: 10.3892/etm.2016.3377. Epub 2016 May 20.

Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus.

Experimental and therapeutic medicine

Chunye Chen, Yuan Zeng, Jing Xu, Hongting Zheng, Jun Liu, Rong Fan, Wenyi Zhu, Lijia Yuan, Yu Qin, Shihui Chen, Yong Zhou, Ying Wu, Jing Wan, Mantian Mi, Jian Wang

Affiliations

  1. Research Center of Nutrition and Food Safety, Chongqing Key Laboratory of Nutrition and Food Safety, Xinqiao Hospital, The Third Military Medical University, Shapingba, Chongqing 400038, P.R. China.
  2. Department of Endocrinology, Xinqiao Hospital, The Third Military Medical University, Shapingba, Chongqing 400038, P.R. China.
  3. Department of Nutrition, Xinqiao Hospital, The Third Military Medical University, Shapingba, Chongqing 400038, P.R. China.

PMID: 27446349 PMCID: PMC4950069 DOI: 10.3892/etm.2016.3377

Abstract

Soluble dietary fiber (DF) reduces the risk of developing diabetes and may have therapeutic effects in patients with type 2 diabetes mellitus (DM2). The present study aimed to investigate the effect of soluble DF on metabolic control in patients with DM2. A total of 117 patients with DM2 between the ages of 40 and 70 were assessed. Patients were randomly assigned to one of two groups, and administered extra soluble DF (10 or 20 g/day), or to a control group (0 g/day) for one month. Blood glucose, serum insulin and connecting peptide (C-peptide) levels, and the insulin resistance index, as determined using the homeostatic model assessment method, were measured during fasting and up to 2-h postprandially prior to and following one month of treatment. Other measurements included serum levels of glycated albumin (GA), blood lipid profiles, and an analysis of the blood pressure, body weight and waist/hip ratio of all patients. Following intervention, the levels of 2-h blood glucose, fasting insulin and lipoprotein(a), and the insulin resistance index, were significantly improved in all groups. Furthermore, the fasting blood glucose, 2-h insulin, fasting C-peptide, 2-h C-peptide, GA and triglyceride (TG) levels were significantly improved in the soluble DF groups. The 20 g/day soluble DF group exhibited significantly improved fasting blood glucose and low-density lipoprotein levels, as well as a significantly improved insulin resistance index. In addition, 10 and 20 g/day soluble DF significantly improved the waist and hip circumferences and levels of TGs and apolipoprotein A. The results of the present study suggested that increased and regular consumption of soluble DF led to significant improvements in blood glucose levels, insulin resistance and metabolic profiles, without improving the secretory function of the islets of Langerhans, over a short-term intervention period in patients with DM2.

Keywords: blood glucose; glycated albumin; insulin resistance index; soluble dietary fiber; type 2 diabetes mellitus

References

  1. Arq Bras Endocrinol Metabol. 2013 Aug;57(6):397-405 - PubMed
  2. Endocr J. 2008 Jul;55(3):503-7 - PubMed
  3. J Am Soc Nephrol. 2007 Mar;18(3):896-903 - PubMed
  4. Gastroenterology. 2010 Jan;138(1):65-72.e1-2 - PubMed
  5. J Clin Endocrinol Metab. 1998 Aug;83(8):2830-5 - PubMed
  6. Diabetes Metab Rev. 1986;2(3-4):331-45 - PubMed
  7. Diabetes Res Clin Pract. 2015 Feb;107(2):300-5 - PubMed
  8. Endocr J. 2007 Feb;54(1):139-44 - PubMed
  9. Physiol Behav. 2008 May 23;94(2):285-92 - PubMed
  10. Circulation. 2002 Dec 17;106(25):3143-421 - PubMed
  11. N Engl J Med. 1976 Jul 22;295(4):207-9 - PubMed
  12. J Toxicol Sci. 2016 Feb;41(1):33-44 - PubMed
  13. Acta Biomed. 2005;76 Suppl 3:59-62 - PubMed
  14. Diabetes Care. 2013 Aug;36(8):2324-30 - PubMed
  15. J Nucl Med. 1996 Oct;37(10 ):1643-8 - PubMed
  16. Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):41-5 - PubMed
  17. Diabetes Care. 1995 Apr;18(4):440-7 - PubMed
  18. Rev Assoc Med Bras (1992). 2009 May-Jun;55(3):308-14 - PubMed
  19. Br Med J. 1978 May 27;1(6124):1392-4 - PubMed
  20. Diabetol Metab Syndr. 2010 Feb 10;2:13 - PubMed
  21. Diabetes Care. 2006 Apr;29(4):775-80 - PubMed
  22. Diabetes Care. 2006 May;29(5):976-81 - PubMed
  23. Vopr Pitan. 2014;83(3):74-81 - PubMed
  24. Diabetes Care. 2000 Jan;23 Suppl 1:S43-6 - PubMed
  25. Dig Dis Sci. 1997 Aug;42(8):1613-7 - PubMed
  26. Perm J. 2013 Summer;17(3):74-9 - PubMed
  27. Diabetes Care. 1981 Nov-Dec;4(6):616-9 - PubMed
  28. Digestion. 1990;46(4):205-13 - PubMed
  29. J Nutr. 2014 Sep;144(9):1445-53 - PubMed
  30. N Engl J Med. 2001 May 3;344(18):1343-50 - PubMed
  31. Gut. 1981 May;22(5):398-403 - PubMed
  32. Lancet. 2008 May 24;371(9626):1783-9 - PubMed
  33. Diabetes Care. 2002 Jan;25(1):202-12 - PubMed
  34. Br J Nutr. 2006 Aug;96 Suppl 1:S89-93 - PubMed
  35. Diabetes Care. 2006 Feb;29(2):207-11 - PubMed
  36. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed
  37. Eur J Clin Nutr. 2002 Sep;56(9):830-42 - PubMed
  38. Am J Gastroenterol. 2006 Dec;101(12):2790-6 - PubMed
  39. Diabetes Care. 2004 Jul;27(7):1761-73 - PubMed
  40. Br J Nutr. 2013 Jul 28;110(2):375-83 - PubMed
  41. Diabetes Metab. 2009 Jun;35(3):185-91 - PubMed
  42. Diabetes Metab Rev. 1994 Jul;10(2):79-90 - PubMed
  43. Am J Clin Nutr. 1994 Apr;59(4):914-21 - PubMed
  44. Diabetes Obes Metab. 2016 Aug;18(8):840-3 - PubMed
  45. J Nutr. 1997 Feb;127(2):359-64 - PubMed
  46. Nutr Res. 2016 Jan;36(1):80-9 - PubMed

Publication Types